Literature DB >> 10366712

Schistosoma TOR (trispanning orphan receptor), a novel, antigenic surface receptor of the blood-dwelling, Schistosoma parasite.

J M Inal1.   

Abstract

Sh-TOR is a novel, putative three transmembrane domain receptor of Schistosoma haematobium, which has no extensive homology to any other known protein. The 0.86 kb open reading frame was found to encode a novel protein, 286 amino acids long and of 32 kDa. It was shown that Sh-TOR can be phosphorylated on tyrosine and the protein sequence reveals a long cytoplasmic tail with several consensus phosphorylation sites for enzymes which characteristically associate with membrane receptors. The proposed topology of Sh-TOR, based on antibody recognition of transfected Sh-TOR, predicts that the amino terminus is extracellular and the carboxyl terminus intracellular. Sh-TOR is a non-glycosylated protein found in the surface tegumental plasma membrane, and tegumental surface pits of adult schistosomes. The 1.35 kb transcript was most highly expressed in the larval stage, which is more susceptible to immune attack. A TOR homologue from Schistosoma mansoni is also described. A homologue from Trypanosoma cruzi, another human parasite was also isolated, but not from the free-living nematode Caenorhabditis elegans. Recombinant Sh-TOR is specifically recognised by a passively protective serum, from baboons vaccinated with irradiated Schistosoma parasite. Together with its surface location, this means that Sh-TOR is also a potential vaccine candidate molecule.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366712     DOI: 10.1016/s0167-4781(99)00051-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Complement C2 receptor inhibitor trispanning: from man to schistosome.

Authors:  Jameel M Inal
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

2.  Inhibition of complement activation by recombinant Sh-CRIT-ed1 analogues.

Authors:  Kwang-Seok Oh; Mee-Hyang Kweon; Ki-Hyeong Rhee; Keyong Ho Lee; Ha-Chin Sung
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

3.  Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasis.

Authors:  C Lochmatter; C L Schneider; K Ingram; J Keiser; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

4.  Characterization of Schistosoma japonicum tetraspanning orphan receptor and its role in binding to complement C2 and immunoprotection against murine schistosomiasis.

Authors:  Shuai Ma; Jinli Zai; Yanhui Han; Yang Hong; Min Zhang; Xiaodan Cao; Qian Han; Ke Lu; Zhixin Zhao; Jiaojiao Lin; Zhiqiang Fu
Journal:  Parasit Vectors       Date:  2017-06-09       Impact factor: 3.876

Review 5.  Evasion Mechanisms Used by Pathogens to Escape the Lectin Complement Pathway.

Authors:  Anne Rosbjerg; Ninette Genster; Katrine Pilely; Peter Garred
Journal:  Front Microbiol       Date:  2017-05-12       Impact factor: 5.640

Review 6.  The Complement System: A Prey of Trypanosoma cruzi.

Authors:  Kárita C F Lidani; Lorena Bavia; Altair R Ambrosio; Iara J de Messias-Reason
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

Review 7.  The emerging role of complement lectin pathway in trypanosomatids: molecular bases in activation, genetic deficiencies, susceptibility to infection, and complement system-based therapeutics.

Authors:  Ingrid Evans-Osses; Iara de Messias-Reason; Marcel I Ramirez
Journal:  ScientificWorldJournal       Date:  2013-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.